vs
Side-by-side financial comparison of TriSalus Life Sciences, Inc. (TLSI) and Zedge, Inc. (ZDGE). Click either name above to swap in a different company.
TriSalus Life Sciences, Inc. is the larger business by last-quarter revenue ($13.2M vs $7.6M, roughly 1.7× Zedge, Inc.). Zedge, Inc. runs the higher net margin — 10.4% vs -73.9%, a 84.2% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 5.8%). Zedge, Inc. produced more free cash flow last quarter ($808.0K vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs -1.0%).
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
Zedge is a content distribution platform that provides consumers with a way to personalize their mobile devices. It has offices in Trondheim, Vilnius, and New York City.
TLSI vs ZDGE — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $13.2M | $7.6M |
| Net Profit | $-9.8M | $788.0K |
| Gross Margin | 86.7% | — |
| Operating Margin | -24.8% | 12.0% |
| Net Margin | -73.9% | 10.4% |
| Revenue YoY | 59.8% | 5.8% |
| Net Profit YoY | 3.5% | 332.4% |
| EPS (diluted) | $-0.22 | $0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.2M | $7.6M | ||
| Q3 25 | $11.6M | $7.5M | ||
| Q2 25 | $11.2M | $7.8M | ||
| Q1 25 | $9.2M | $7.0M | ||
| Q4 24 | $8.3M | $7.2M | ||
| Q3 24 | $7.3M | $7.6M | ||
| Q2 24 | $7.4M | $7.7M | ||
| Q1 24 | $6.5M | $7.8M |
| Q4 25 | $-9.8M | $788.0K | ||
| Q3 25 | $-10.8M | $-559.0K | ||
| Q2 25 | $-8.3M | $185.0K | ||
| Q1 25 | $-10.4M | $-1.7M | ||
| Q4 24 | $-10.1M | $-339.0K | ||
| Q3 24 | $-2.4M | $-39.0K | ||
| Q2 24 | $-4.3M | $113.0K | ||
| Q1 24 | $-13.2M | $-9.2M |
| Q4 25 | 86.7% | — | ||
| Q3 25 | 83.5% | — | ||
| Q2 25 | 83.9% | — | ||
| Q1 25 | 83.7% | — | ||
| Q4 24 | 85.3% | — | ||
| Q3 24 | 86.3% | — | ||
| Q2 24 | 87.6% | — | ||
| Q1 24 | 85.0% | — |
| Q4 25 | -24.8% | 12.0% | ||
| Q3 25 | -77.9% | -9.6% | ||
| Q2 25 | -65.4% | 2.1% | ||
| Q1 25 | -79.9% | -31.8% | ||
| Q4 24 | -91.8% | -6.4% | ||
| Q3 24 | -118.9% | -0.8% | ||
| Q2 24 | -111.0% | -1.7% | ||
| Q1 24 | -180.8% | -153.5% |
| Q4 25 | -73.9% | 10.4% | ||
| Q3 25 | -93.5% | -7.5% | ||
| Q2 25 | -73.9% | 2.4% | ||
| Q1 25 | -113.2% | -24.1% | ||
| Q4 24 | -122.4% | -4.7% | ||
| Q3 24 | -32.6% | -0.5% | ||
| Q2 24 | -58.8% | 1.5% | ||
| Q1 24 | -204.5% | -118.8% |
| Q4 25 | $-0.22 | $0.06 | ||
| Q3 25 | $-0.96 | $-0.04 | ||
| Q2 25 | $-0.27 | $0.01 | ||
| Q1 25 | $-0.39 | $-0.12 | ||
| Q4 24 | $-0.38 | $-0.02 | ||
| Q3 24 | $-0.12 | $0.00 | ||
| Q2 24 | $-0.21 | $0.01 | ||
| Q1 24 | $-0.60 | $-0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $20.4M | $18.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-33.9M | $25.9M |
| Total Assets | $35.3M | $36.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.4M | $18.5M | ||
| Q3 25 | $22.7M | $18.6M | ||
| Q2 25 | $26.5M | $20.4M | ||
| Q1 25 | $13.0M | $20.1M | ||
| Q4 24 | $8.5M | $20.2M | ||
| Q3 24 | $11.3M | $20.0M | ||
| Q2 24 | $16.5M | $19.9M | ||
| Q1 24 | $4.0M | $18.1M |
| Q4 25 | $-33.9M | $25.9M | ||
| Q3 25 | $-26.7M | $25.9M | ||
| Q2 25 | $-19.4M | $28.6M | ||
| Q1 25 | $-34.4M | $28.2M | ||
| Q4 24 | $-25.9M | $30.1M | ||
| Q3 24 | $-20.4M | $30.9M | ||
| Q2 24 | $-25.3M | $30.9M | ||
| Q1 24 | $-36.0M | $30.7M |
| Q4 25 | $35.3M | $36.0M | ||
| Q3 25 | $36.5M | $35.7M | ||
| Q2 25 | $41.3M | $37.8M | ||
| Q1 25 | $28.6M | $37.1M | ||
| Q4 24 | $24.0M | $38.2M | ||
| Q3 24 | $27.5M | $38.2M | ||
| Q2 24 | $32.4M | $38.1M | ||
| Q1 24 | $17.9M | $37.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $825.0K |
| Free Cash FlowOCF − Capex | $-2.5M | $808.0K |
| FCF MarginFCF / Revenue | -19.1% | 10.6% |
| Capex IntensityCapex / Revenue | 0.3% | 0.2% |
| Cash ConversionOCF / Net Profit | — | 1.05× |
| TTM Free Cash FlowTrailing 4 quarters | $-19.1M | $3.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $825.0K | ||
| Q3 25 | $-3.7M | $674.0K | ||
| Q2 25 | $-7.3M | $870.0K | ||
| Q1 25 | $-4.5M | $708.0K | ||
| Q4 24 | $-5.7M | $1.2M | ||
| Q3 24 | $-10.8M | $695.0K | ||
| Q2 24 | $-13.4M | $2.3M | ||
| Q1 24 | $-10.9M | $1.6M |
| Q4 25 | $-2.5M | $808.0K | ||
| Q3 25 | $-3.9M | $640.0K | ||
| Q2 25 | $-7.4M | $851.0K | ||
| Q1 25 | $-5.3M | $689.0K | ||
| Q4 24 | $-5.8M | $1.2M | ||
| Q3 24 | $-11.0M | $683.0K | ||
| Q2 24 | $-13.5M | $2.3M | ||
| Q1 24 | $-10.9M | $1.6M |
| Q4 25 | -19.1% | 10.6% | ||
| Q3 25 | -33.9% | 8.6% | ||
| Q2 25 | -66.1% | 11.0% | ||
| Q1 25 | -57.3% | 9.9% | ||
| Q4 24 | -69.7% | 16.1% | ||
| Q3 24 | -149.9% | 9.0% | ||
| Q2 24 | -183.1% | 30.4% | ||
| Q1 24 | -169.3% | 20.0% |
| Q4 25 | 0.3% | 0.2% | ||
| Q3 25 | 1.9% | 0.5% | ||
| Q2 25 | 0.8% | 0.2% | ||
| Q1 25 | 8.2% | 0.3% | ||
| Q4 24 | 0.6% | 0.2% | ||
| Q3 24 | 2.3% | 0.2% | ||
| Q2 24 | 0.8% | 0.2% | ||
| Q1 24 | 1.0% | 0.0% |
| Q4 25 | — | 1.05× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.70× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 20.73× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
TLSI
Segment breakdown not available.
ZDGE
| Zedge Marketplace | $7.1M | 94% |
| Other | $468.0K | 6% |
